Jérôme Braudeau is a CEO and co-founder of AgenT, a biotechnology company that specializes in the development of innovative therapies for age-related diseases. Jérôme has a strong background in neuroscience, holding a Doctor of Philosophy (PhD) in the field from Université Paris - Val-de-Marne, and has worked as a researcher and postdoctoral researcher at various organizations like CEA, INSERM, CR-ICM, and CNRS. Along with his academic background, he has also completed various practical training courses like intellectual property, animal experimentation, and entrepreneurship, especially at CEA.

Jérôme has a passion for developing innovative therapies that help people in their old age, and his work at AgenT is a testament to that. He has years of experience in research and development in the field of neuroscience, which aids him in coming up with new ideas for treatments. He is also very knowledgeable in IP, which is crucial in the biotechnology industry.

Overall, Jérôme is a seasoned CEO with extensive expertise in neuroscience research and development, intellectual property and entrepreneurship, making him the perfect candidate to lead AgenT to a brighter future.